Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Future prospects for treatment of hemoglobinopathies Stamatoyannopoulos JAWest J Med 1992[Dec]; 157 (6): 631-6Strategies for the treatment of sickle cell anemia and beta-thalassemia are founded on the knowledge that these disorders result from structural or functional defects in an adult gene for which an intact fetal counterpart exists. During the past decade, several pharmacologic agents have been investigated for their potential to ameliorate sickle cell anemia and beta-thalassemia by increasing the synthesis of fetal hemoglobin in adults. Progress in understanding globin gene regulation is now being combined with advances in retrovirus-mediated gene transfer, and the once-distant goal of providing gene therapy for hemoglobinopathies is rapidly approaching reality.|*Genetic Therapy[MESH]|Adult[MESH]|Anemia, Sickle Cell/genetics/metabolism/*therapy[MESH]|Fetal Hemoglobin/biosynthesis/genetics[MESH]|Genetic Vectors[MESH]|Hemoglobins/genetics[MESH]|Humans[MESH]|Plasmids[MESH]|Retroviridae Proteins/therapeutic use[MESH]|Retroviridae/genetics[MESH]|Transfection[MESH]|beta-Thalassemia/genetics/metabolism/*therapy[MESH] |
